4
Changes in Ownership
Syndax Pharmaceuticals Inc Filed Acc 0001562180-22-001081
Options or other derivatives
- Chief Executive Officer acquired 325,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Metzger Michael A · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-02 | Grant or award : show line 1 in the form Stock Options (Right to buy) | +325,000 | $15.79 | $5,131,750 | 325,000 | D |
Loading xslF345X03/primarydocument.xml…